Clin2
NCT07413536Worth exploringNot yet recruiting

Healthy volunteer study of a new antibody drug

Health Adult Subjects

This study tests a new antibody-based drug in healthy volunteers to see how safe it is and how the body handles it. Participants will receive a single injection and be monitored closely for a few months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • Your body mass index (BMI) is between 18 and 26, which usually means a healthy weight for your height.
  • You are in overall good health, with no major illnesses or chronic conditions.
  • You do not smoke more than a few cigarettes a day and can stop smoking during the study.
  • You can avoid taking most medications and supplements for two weeks before the study starts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07847697Not yet recruiting· Phase 1
Safety study of an experimental antibody in healthy men

This early-phase trial tests a new antibody-based therapy called SCTB10 in healthy volunteers to see if it's safe and how the body processes it. Participation can help determine the right dose for future patients.

Tianjin
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT07087262Recruiting· Phase 1
Study of a new medicine called SNH-119014 in healthy volunteers

This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.

Hefei, Anhui
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah

Hear when a new Health Adult Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.